Profound Medical Corp. (PROF) stock: key figures, P/E, revenue and dividend
Health Care · Canada · ISIN CA74319B5027
Profound Medical Corp. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 16.10 m USD |
| Gross profit | 11.39 m USD |
| Operating income | -41.25 m USD |
| EBIT | -41.92 m USD |
| Net income | -42.57 m USD |
| Diluted EPS – continuing operations | 1.41 USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Profound Medical Corp.
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.
More stocks
- Tivan Ltd (TVN.AX)
- Shanghai Huaming Intelligent Terminal Equipment Co Ltd (300462.SZ)
- Doosan Fuel Cell Co. Ltd. Pfd. Series 1 (33626K.KS)
- Jiangsu Huaxin New Material Co Ltd Class A (300717.SZ)
- Shenzhen New Land Co Ltd (300778.SZ)
- Thaicom Public Company Limited (THCOM.BK)
- HAWTHORN BANCSHARES, INC. (HWBK)
- Oak Valley Bancorp (OVLY)
- StealthGas Inc (GASS)
- Orchestra BioMed Holdings, Inc. (OBIO)
- Tus Pharmaceutical Group Co Ltd (000590.SZ)
- VEEA INC. (VEEA)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.